Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study

Figure 2

Longitudinal variation in IgG anti-apoA-1 levels and global BILAG score in eight patients with SLE over time. Time points on the x axis are successive follow-up visits. IgG anti-apoA-1 parallels global disease activity in many (A) to (F) but not all (G), (H) patients. anti-apoA-1, antibodies to apolipoprotein A-1; AU, absorbance units; BILAG, British Isles Lupus Assessment Group; IgG, immunoglobulin G.

Back to article page